/

Parvus Therapeutics

Developing pMHC nanomedicine treatments for autoimmune diseases.

BiotechnologyPharmaceuticals parvustx.com ↗

Company facts

Founded: 2007
Employees: 50
Headquarters: United States
Type: Private
Funding: Corporate Round · $14.5M · 2017